Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2908 results
Prostate cancer cell

Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer. Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer.

by Cancer Research UK | News | 30 November 2020

30 November 2020

Senedd in Wales.

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

by Cancer Research UK | News | 20 November 2020

20 November 2020

Lung cancer cells under a microscope

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

by Cancer Research UK | News | 13 November 2020

13 November 2020

A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries. A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries.

by Cancer Research UK | News | 13 November 2020

13 November 2020

blood samples

Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer. Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.

by Lilly Matson | Analysis | 28 October 2020

28 October 2020

An illustration of T cells (white) attacking a tumour (purple)

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

by Cancer Research UK | News | 26 October 2020

26 October 2020